The goal of this real-life, national, multicentre, prospective clinical investigation is to describe the adherence rate over time in patients with glaucoma or OHT already treated with IOP-lowering eye drops using connected device CONNECTDROP®
The main questions it aims to answer are:
* The mean annual adherence rate, defined as the percentage of the prescribed doses taken by the patient * The adherence profile of each patient * The association between the adherence profile, the objective adherence data and the clinical data.
Participants will use the connected device CONNECTDROP® associated with the smartphone application on a daily basis.
Adult patient (≥ 18 years old), man or woman
Patient with a diagnosis of bilateral open angle glaucoma or OHT
Patients being prescribed with glaucoma eye drops in EASYGRIP® bottle for at least 6 weeks in monotherapy.
Patient willing to participate in the study
Pregnant and/or lactating woman
Patient receiving another ocular treatment for a chronic condition (i.e. regular instillations for several months)
Protected patient: adult under guardianship, curatorship or other protection legal, deprived of liberty by judicial or administrative decision
Glaucoma or OHT patients from hospital and/or private practice
Cohort
Prospective
Not listed
Adherence rate over time in patients with glaucoma or OHT already treated with IOP-lowering eye drops in EASYGRIP® bottle clipped with CONNECTDROP®
Assessment of the mean annual adherence rate, defined as the percentage of the prescribed doses actually taken by the patient (i.e. at least 2 instillations per day).
Click on the lead sponsor to view all of their trials.
